Tonix Pharma’s Potential PTSD Cure: A Game-Changer? by Mark Eisenberg 12.02.2024 Tonix Pharmaceuticals receives FDA clearance for its OASIS trial, evaluating the efficacy of TNX-102 SL in treating acute stress reactions ...
AN2 Therapeutics Pauses Trial: Efficacy Concerns Rise by Mark Eisenberg 12.02.2024 AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...
Atossa Genetics: Potential Breakthrough in Breast Cancer? by Lilu Anderson 12.02.2024 Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
Asian Stocks Stagnate, Eyes on Fed Insights by Mark Eisenberg 12.02.2024 Asian stocks traded in a narrow range due to many major markets being closed for Chinese New Year. Australian market ...
CSL Shares Plunge Amid Failed Heart Drug Trial by Mark Eisenberg 12.02.2024 Shares of pharmaceutical firm CSL are set for their worst day in four months as the company announced disappointing results ...
Wexner Medical Center Utilizes RT-MRIs in Neurological Gene Therapy by Lilu Anderson 24.01.2024 Discover how surgeons are using real-time MRIs to enhance the safety and efficacy of gene therapy surgeries, revolutionizing the approach ...
Embracing Virtual Reality: A New Frontier in GI Healthcare by Lilu Anderson 20.01.2024 Discover how Virtual Reality (VR) is revolutionizing gastrointestinal healthcare by modulating the mind-gut connection in this informative article. #VR #healthtech ...